logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Molecular profiling of "exceptional responders" to cancer treatment is possible

Feasibility study retrospectively identifies exceptional responders and sequenced archived tissue.